EE200100096A - Asatsüklilise tüvistruktuuriga tsükliline ühend, seda sisaldav farmatseutiline kompositsioon ning selle kasutamine ravimina - Google Patents

Asatsüklilise tüvistruktuuriga tsükliline ühend, seda sisaldav farmatseutiline kompositsioon ning selle kasutamine ravimina

Info

Publication number
EE200100096A
EE200100096A EEP200100096A EEP200100096A EE200100096A EE 200100096 A EE200100096 A EE 200100096A EE P200100096 A EEP200100096 A EE P200100096A EE P200100096 A EEP200100096 A EE P200100096A EE 200100096 A EE200100096 A EE 200100096A
Authority
EE
Estonia
Prior art keywords
azacyclic
medicament
pharmaceutical composition
composition containing
cyclic compound
Prior art date
Application number
EEP200100096A
Other languages
English (en)
Estonian (et)
Inventor
Grewal Gurmit
Toy-Palmer Anna
Cai Xiong
Mark Latham George
Original Assignee
Ucb, S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb, S.A. filed Critical Ucb, S.A.
Publication of EE200100096A publication Critical patent/EE200100096A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/18—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Plural Heterocyclic Compounds (AREA)
EEP200100096A 1998-08-18 1999-08-16 Asatsüklilise tüvistruktuuriga tsükliline ühend, seda sisaldav farmatseutiline kompositsioon ning selle kasutamine ravimina EE200100096A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9697798P 1998-08-18 1998-08-18
PCT/US1999/018570 WO2000011001A1 (en) 1998-08-18 1999-08-16 Muscarinic agonists and antagonists

Publications (1)

Publication Number Publication Date
EE200100096A true EE200100096A (et) 2002-06-17

Family

ID=22260061

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200100096A EE200100096A (et) 1998-08-18 1999-08-16 Asatsüklilise tüvistruktuuriga tsükliline ühend, seda sisaldav farmatseutiline kompositsioon ning selle kasutamine ravimina

Country Status (30)

Country Link
US (5) US6093724A (xx)
EP (1) EP1112272B1 (xx)
JP (1) JP2002523416A (xx)
KR (1) KR20010072784A (xx)
CN (1) CN1312812A (xx)
AR (1) AR020199A1 (xx)
AT (1) ATE227724T1 (xx)
AU (1) AU750566B2 (xx)
BG (1) BG105256A (xx)
BR (1) BR9913072A (xx)
CA (1) CA2340946A1 (xx)
CO (1) CO5130018A1 (xx)
DE (1) DE69903961T2 (xx)
EE (1) EE200100096A (xx)
ES (1) ES2191455T3 (xx)
HK (1) HK1038918A1 (xx)
HU (1) HUP0103203A3 (xx)
ID (1) ID27544A (xx)
IL (1) IL141050A0 (xx)
IS (1) IS5827A (xx)
NO (1) NO20010804L (xx)
NZ (1) NZ509762A (xx)
PE (1) PE20000988A1 (xx)
PL (1) PL346247A1 (xx)
RU (1) RU2219179C2 (xx)
SK (1) SK1892001A3 (xx)
TR (1) TR200100462T2 (xx)
WO (1) WO2000011001A1 (xx)
YU (1) YU13301A (xx)
ZA (1) ZA200100978B (xx)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA03003475A (es) * 2000-10-19 2003-07-14 Pfizer Prod Inc Derivados puente de piperazina.
GB0117950D0 (en) * 2001-02-16 2001-09-19 Aventis Pharma Inc Novel heterocyclic urea derivatives andd their use as dopamine D3 receptor ligands
WO2002094827A1 (en) * 2001-05-23 2002-11-28 Neurosearch A/S Fused tropane derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
US20030064979A1 (en) * 2001-06-29 2003-04-03 Hansen Thomas Kruse Method of inhibiting PTP 1B and /or T-cell PTP and/or other PTPases with an Asp residue at position 48
US6828328B1 (en) * 2002-03-01 2004-12-07 Ucb S.A. Analgesic combination of muscarinic agonists
US7897766B2 (en) 2005-09-23 2011-03-01 Abbott Laboratories Amino-aza-adamantane derivatives and methods of use
US8314119B2 (en) 2006-11-06 2012-11-20 Abbvie Inc. Azaadamantane derivatives and methods of use
US8076350B2 (en) * 2006-12-22 2011-12-13 Abbott Laboratories Spirocyclic azaadamantane derivatives and methods of use
ES2391596T3 (es) * 2007-03-23 2012-11-28 Abbott Laboratories Derivados de azaadamantano 4-sustituidos y métodos de uso de los mismos
ES2378116T3 (es) 2007-03-23 2012-04-09 Abbott Laboratories Derivados acetamida y carboxamida de azaadamantano y métodos de uso de los mismos
CN102459268A (zh) * 2009-06-19 2012-05-16 雅培制药有限公司 二氮杂高金刚烷衍生物和其使用方法
HUE044653T2 (hu) 2009-07-22 2019-11-28 PureTech Health LLC Készítmények olyan rendellenességek kezelésére, amelyek muszkarin-receptor aktiválással enyhíthetõk
US10265311B2 (en) 2009-07-22 2019-04-23 PureTech Health LLC Methods and compositions for treatment of disorders ameliorated by muscarinic receptor activation
AR081626A1 (es) 2010-04-23 2012-10-10 Cytokinetics Inc Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
EP2560488B1 (en) 2010-04-23 2015-10-28 Cytokinetics, Inc. Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
AU2011305462B2 (en) 2010-09-23 2015-11-26 Abbvie Bahamas Ltd. Monohydrate of an azaadamantane derivative
US8759380B2 (en) 2011-04-22 2014-06-24 Cytokinetics, Inc. Certain heterocycles, compositions thereof, and methods for their use
EP3732163A4 (en) * 2017-12-20 2021-07-14 Vanderbilt University MUSCARINIAN ACETYLCHOLINE RECEPTOR ANTAGONISTS M4
MX2021003621A (es) 2018-09-28 2022-04-13 Karuna Therapeutics Inc Composiciones y metodos para tratar trastornos mejorados por medio de activacion de receptor muscarinico.

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4739074A (en) * 1986-01-22 1988-04-19 Pennwalt Corporation Adamantane spiro-pyrrolidine derivatives
IE63906B1 (en) * 1987-11-13 1995-06-14 Novo Nordisk As Azabicyclic compounds and their preparation and use
US5527813A (en) * 1990-08-21 1996-06-18 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
JPH06502616A (ja) * 1990-12-21 1994-03-24 メルク　シヤープ　エンド　ドーム　リミテツド 治療用化合物
US5955470A (en) * 1991-06-11 1999-09-21 Merrell Pharmaceuticals, Inc. Derivatives of amide analogs of certain methano bridged quinolizines
US5641791A (en) * 1991-08-13 1997-06-24 Novo Nordisk A.S Heterocyclic compounds and their preparation and use
AU702720B2 (en) * 1995-11-02 1999-03-04 Neurosearch A/S Fused tropane-derivatives as neurotransmitter reuptake inhibitors
US5914338A (en) * 1996-04-02 1999-06-22 Novo Nordisk Heterocyclic compounds and their preparation and use
US6057446A (en) * 1998-04-02 2000-05-02 Crooks; Peter Anthony Certain 1-aza-tricyclo [3.3.1-13,7 ] decane compounds
US5952339A (en) * 1998-04-02 1999-09-14 Bencherif; Merouane Pharmaceutical compositions and methods of using nicotinic antagonists for treating a condition or disorder characterized by alteration in normal neurotransmitter release
US5986100A (en) * 1998-04-02 1999-11-16 Crooks; Peter Anthony Pharmaceutical compositions and methods for use

Also Published As

Publication number Publication date
DE69903961T2 (de) 2003-07-03
TR200100462T2 (tr) 2001-09-21
WO2000011001A1 (en) 2000-03-02
AR020199A1 (es) 2002-05-02
KR20010072784A (ko) 2001-07-31
BG105256A (en) 2001-11-30
JP2002523416A (ja) 2002-07-30
HUP0103203A2 (hu) 2002-01-28
CO5130018A1 (es) 2002-02-27
NO20010804L (no) 2001-04-11
ES2191455T3 (es) 2003-09-01
NO20010804D0 (no) 2001-02-16
US20020045617A1 (en) 2002-04-18
US6323194B1 (en) 2001-11-27
HUP0103203A3 (en) 2002-10-28
ZA200100978B (en) 2002-02-05
AU5775899A (en) 2000-03-14
US6423842B1 (en) 2002-07-23
BR9913072A (pt) 2001-05-15
HK1038918A1 (zh) 2002-04-04
EP1112272B1 (en) 2002-11-13
EP1112272A1 (en) 2001-07-04
NZ509762A (en) 2002-12-20
US6251916B1 (en) 2001-06-26
IL141050A0 (en) 2002-02-10
US6093724A (en) 2000-07-25
CN1312812A (zh) 2001-09-12
ATE227724T1 (de) 2002-11-15
IS5827A (is) 2001-01-26
AU750566B2 (en) 2002-07-25
RU2219179C2 (ru) 2003-12-20
PE20000988A1 (es) 2000-09-30
ID27544A (id) 2001-04-12
SK1892001A3 (en) 2001-11-06
CA2340946A1 (en) 2000-03-02
DE69903961D1 (de) 2002-12-19
US6555550B1 (en) 2003-04-29
PL346247A1 (en) 2002-01-28
YU13301A (sh) 2005-06-10

Similar Documents

Publication Publication Date Title
EE200100096A (et) Asatsüklilise tüvistruktuuriga tsükliline ühend, seda sisaldav farmatseutiline kompositsioon ning selle kasutamine ravimina
IL144910A0 (en) Cyclic compounds and pharmaceutical compositions containing the same
IL142531A0 (en) Cyclic peptide compound, processes for the preparation thereof and pharmaceutical compositions containing the same
IL172695A0 (en) Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics
BR0014526B1 (pt) compostos cíclicos de seis elementos contendo nitrogênio aromático, composição farmacêutica e uso do mesmo
FI991485A0 (fi) Uusi farmaseuttinen koostumus
MXPA03004936A (es) Compuestos ciclicos fusionados y uso medicinal de los mismos.
HUP0103265A3 (en) Cyclic prosaposin-derived peptides, pharmaceutical compositions comprising thereof and their use
HK1068895A1 (en) Nitrogen-containing heterocyclic derivative, medicinal composition containing the same, medicinal use thereof, and intermediate therefor
IL159086A0 (en) 3-aryl-5-aryl- [1, 2, 4] -oxadiazole derivatives and pharmaceutical compositions containing the same
TR200003787A3 (tr) Kararli yavas salimli oral dozaj bilesimi.
HUP0401733A3 (en) Cyclic amine-derivatives and pharmaceutical compositions containing them
DE10084344T1 (de) Cyclosporin enthaltende pharmazeutische Zusammensetzung
EE04811B1 (et) Asendatud 3-fenüül-5-alkoksü-1,3,4-oksdiasool-2-oon, selle valmistamine ja kasutamine lipaasi inhibiitorina ning seda sisaldav ravim
EE200300398A (et) Isoksasoliini derivaat, selle saamine ja kasutamine depresioonivastase ravimi valmistamiseks ning seda sisaldav ravimkompositsioon
PT1227817E (pt) Composicao farmaceutica aquosa contendo ciclesonida
EE05406B1 (et) Memnopeptiidhend, selle valmistamine ja kasutamine ning seda sisaldav farmatseutiline kompositsioon
HUP0201696A3 (en) Cyclic peptides, pharmaceutical compositions comprising thereof and their use
IL150904A0 (en) Cyclic hexapeptide derivatives and pharmaceutical compositions containing the same
NO20014692L (no) 3-amidinobenzensulfonamidderivater, medisinske sammensetninger inneholdende slike samt intermediater vedfremstillingen derav
ITTO20010028A0 (it) Metodo per aumentare l'attivita' antitumorale di una sostanza contenente amigdalina, composizione contenente una sostanza con contenuto aume
FR2796382B1 (fr) Organopolysiloxanes modifies, leur preparation, et compositions en contenant
HUP0104623A3 (en) Cyclosporin solution, pharmaceutical composition comprising thereof and its use
HUP0402072A3 (en) Glycine derivatives containing 1,3-oxazole or -thiazole ring and drugs containing the same as active ingredient
HK1054932A1 (en) Cyclic substituted aminomethyl compounds and medicaments containing said compounds.